top of page

Proteometer™ Kits 

Proteometer-L Starter Kit 

The Proteometer-L Starter Kit transforms any LC into an analytical system capable of identifying and quantifying molecular structure in crude culture filtrate in 10 minutes, without sample preparation.

This at-line solution provides time and money savings of up to 6+ hours and over $100,000 per batch by eliminating the hours of sample preparation traditionally required for molecular analysis. 

Applications include manufacturing, drug development, process R&D, discovery, and more. 

Additional product information can be found on our literature page

Features & Benefits 

  • mAb Titer and aggregate detection and quantification in one assay

  • No mass spec needed!

  • Eliminate sample pretreatment

  • Utilize your existing instruments

  • ≤ 10μL sample of crude culture filtrate

  • < 10 mins per analysis

Kit Components

  • Proteometer-L Reactor

  • Proteometer-L Reagent

  • Proteometer-L Buffer

  • Proteometer-L Reconstitution Reagent

  • Instructions for use



Architectural Structure

"As analytical tools have matured for the quality control and characterization of isolated biopharmaceuticals, the application of advanced analytical systems to dynamically contribute to process monitoring and control in complex bioreactors is critical for enhanced process efficiency and product quality.


The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies. The integration of complementary bioprocess analytical data facilitates decision-making through a powerful link between the manufacturing space and the QC laboratory."

Eugene L. Inman, Ph.D.

Pharmaceutical Quality Consultant

Retired Eli Lilly and Company

Architectural Structure

“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.


The approach improves product safety, reduces COPQ and post release testing, and paves the way for real-time product release, reducing inventory costs. 


The solution combines novel sample handing and artificial intelligence with proven analytical technology that is easy to deploy and support, and provides near instantaneous ROI.”

Martin Long, BSc.
Performance Validation, Inc. – President & CEO
(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)

bottom of page